We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

515 hedge funds and large institutions have $10.7B invested in Bio-Rad Laboratories Class A in 2022 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 189 increasing their positions, 191 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.27% more ownership

Funds ownership: 77.08% → 77.36% (+0.27%)

1% less repeat investments, than reductions

Existing positions increased: 189 | Existing positions reduced: 191

3% less funds holding

Funds holding: 533 → 515 (-18)

12% less first-time investments, than exits

New positions opened: 68 | Existing positions closed: 77

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

25% less capital invested

Capital invested by funds: $14.3B → $10.7B (-$3.59B)

37% less call options, than puts

Call options by funds: $58.3M | Put options by funds: $92M

Holders
515
Holders Change
-18
Holders Change %
-3.38%
% of All Funds
8.12%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
68
Increased
189
Reduced
191
Closed
77
Calls
$58.3M
Puts
$92M
Net Calls
-$33.7M
Net Calls Change
+$33.3M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$158M
2
Marshall Wace
Marshall Wace
United Kingdom
+$80.8M
3
Renaissance Technologies
Renaissance Technologies
New York
+$79.3M
4
Citadel Advisors
Citadel Advisors
Florida
+$76.9M
5
NC
Nitorum Capital
New York
+$66.6M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$602M
2
IIP
Intermede Investment Partners
United Kingdom
-$171M
3
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$33.9M
4
APG Asset Management
APG Asset Management
Netherlands
-$30.4M
5
Morgan Stanley
Morgan Stanley
New York
-$29.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.31B +$18.4M +30,476 +1%
BlackRock
2
BlackRock
New York
$991M -$4.8M -7,955 -0.4%
State Street
3
State Street
Massachusetts
$555M -$14.5M -24,002 -2%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$524M -$602M -998,111 -52%
AllianceBernstein
5
AllianceBernstein
Tennessee
$368M +$39.9M +66,258 +11%
Brown Advisory
6
Brown Advisory
Maryland
$328M +$25.5M +42,375 +8%
Marshall Wace
7
Marshall Wace
United Kingdom
$263M +$80.8M +133,973 +40%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$247M +$7.53M +12,499 +3%
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$234M +$2.44M +4,048 +1%
Bank of America
10
Bank of America
North Carolina
$222M +$14.4M +23,848 +6%
Invesco
11
Invesco
Georgia
$198M +$21.5M +35,635 +11%
UBS AM
12
UBS AM
Illinois
$195M +$1.5M +2,495 +0.7%
Westfield Capital Management
13
Westfield Capital Management
Massachusetts
$193M +$6.1M +10,113 +3%
AQR Capital Management
14
AQR Capital Management
Connecticut
$164M +$37.2M +61,695 +27%
Millennium Management
15
Millennium Management
New York
$163M +$158M +261,317 +914%
Allspring Global Investments
16
Allspring Global Investments
North Carolina
$160M +$16M +26,539 +10%
Northern Trust
17
Northern Trust
Illinois
$143M -$144K -239 -0.1%
CIP
18
Champlain Investment Partners
Vermont
$138M -$163K -270 -0.1%
Franklin Resources
19
Franklin Resources
California
$127M -$1.16M -1,930 -0.8%
Norges Bank
20
Norges Bank
Norway
$118M -$2.4M -3,989 -2%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$109M -$2.55M -4,232 -2%
EARNEST Partners
22
EARNEST Partners
Georgia
$108M +$820K +1,360 +0.7%
Renaissance Technologies
23
Renaissance Technologies
New York
$106M +$79.3M +131,600 +234%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$99.8M +$130K +216 +0.1%
Charles Schwab
25
Charles Schwab
California
$98M +$3.26M +5,416 +3%
1
2 3 4 5

BIO Hedge Fund Activity: Q1 2022 in Review

515 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q1 2022, worth a combined $10.7B — down 25% from $14.3B a quarter earlier.

Sellers outnumbered buyers: 77 funds closed out of BIO and 68 opened new positions — a net loss of 9 holders — while 191 trimmed existing stakes and 189 added.

The largest buyer was Millennium Management, adding an estimated $158M. The largest seller was Fidelity Investments, cutting an estimated $602M.

  • 515 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q1 2022, down from 533 in Q4 2021.
  • Funds reported $10.7B of Bio-Rad Laboratories Class A stock for Q1 2022, down 25% quarter-over-quarter.
  • 68 funds opened new Bio-Rad Laboratories Class A positions in Q1 2022 and 77 closed out, a net change of -9 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q1 2022 was Millennium Management, an estimated $158M added.
  • The largest Bio-Rad Laboratories Class A seller in Q1 2022 was Fidelity Investments, an estimated $602M sold.

Based on aggregated 13F filings for Q1 2022.